RADX
Radiopharm Theranostics Limited
NASDAQ · Healthcare · Biotechnology · AU
$2.08
−3.48%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -0.17x
- Debt / assets
- 0.00x
- Debt / EBITDA
- 0.00x
- Net debt / EBITDA
- 0.06x
Liquidity & coverage
- Current ratio
- 1.16x
- Quick ratio
- 1.16x
- Cash ratio
- 0.22x
- Interest coverage
- -607.93x
- EBITDA / interest
- -607.93x
- Working capital
- $2.2M
Cash & dividend
- FCF / debt
- —
- Cash flow / debt
- —
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026